Concerns over falling vaccination coverage within National Immunisation Programme The percentage of children vaccinated within the National Immunisation Programme (NIP) has fallen for the second year in a row, according to the 2022 report ‘Vaccination Coverage and Annual Report of the Dutch National Immunisation Programme'. RIVM is concerned about this decline.
More STIs diagnosed in 2022, most significant increase in gonorrhoea More people got tested for an STI at Sexual Health Centres (SHCs) in 2022 than in 2021. There were a total of 164,715 consultations at SHCs. The percentage of people found to have an STI (21%) was also higher than in 2021.
Fewer people feel healthy In 2022, 7 out of 10 adults in the Netherlands perceived their own health as good or very good. In late 2020, this was still 8 out of 10 people. Furthermore, there are large differences between regions and population groups in this regard.
Mercury in Groningen’s natural gas not harmful to health Mercury can be naturally present in natural gas. This mercury can end up in your home, especially if you use a natural gas cooker. In 2014, the Nederlandse Aardolie Maatschappij (NAM) calculated exposure to mercury at daily peak moments.
Impact of coronavirus outbreak on participation in National Immunisation Programme limited Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).
Start cervical cancer screening on Saba February 7th 2022, a pilot for population screening for cervical cancer will start on Saba. All women between 30 and 60 years, will be invited to participate in the coming three years.
At least 87% of people over 65 vaccinated at least once: high turnout, few regional differences Four months after the launch of the vaccination campaign, at least 87% of people over 65 in the Netherlands have been vaccinated against COVID-19 at least once.
Quality assessment of SARS-CoV-2 antigen test diagnostics: good performance at public test sites in the Netherlands In their role as WHO reference laboratories, RIVM and Erasmus UMC conducted a study on the quality of SARS-CoV-2 antigen diagnostics in the Netherlands.
Long-term symptoms more common after Lyme disease More than a quarter of people with Lyme disease continue to have long-term symptoms that lead to limitations in daily life even after treatment.
RIVM updates guidelines for AstraZeneca interval As of 21 May, RIVM updated the guidelines for the interval between two doses of the AstraZeneca vaccine. The interval can now be between 6 and 14 weeks.